Related Experiment Video
Updated: Sep 14, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Type 2 Cardiorenal Syndrome: Prevalence and Correlates in Nigerian Heart Failure Patients
Daniel Gilbert Uchendu1, Basil Nwaneri Okeahialam2, Lucius Chidiebere Imoh3
1Renal Unit, Department of Medicine, Jos University Teaching Hospital, Plateau State, Nigeria.
Insights
Type 2 cardiorenal syndrome (CRS) affects 37.5% of heart failure patients, with diabetes and heart dysfunction as key predictors. Early CKD screening in heart failure patients is crucial to prevent severe kidney disease.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Type 2 cardiorenal syndrome (CRS) links chronic congestive heart failure (HF) to progressive chronic kidney disease (CKD).
- HF and CKD share cardiovascular risk factors and exhibit a bi-directional relationship.
- A multidisciplinary approach is vital for reducing morbidity and mortality in these patients.
Purpose of the Study:
- To determine the prevalence of Type 2 CRS among heart failure patients.
- To identify correlates and predictors of Type 2 CRS in this population.
- To assess the burden of cardiorenal syndrome in Jos, Nigeria.
Main Methods:
- A hospital-based cross-sectional descriptive study was conducted.
- 120 patients with chronic heart failure were consecutively recruited.
- CKD was diagnosed using estimated glomerular filtration rate (eGFR) and persistent albuminuria.
Main Results:
- The prevalence of Type 2 CRS was 37.5%, with most cases being mild (66.7%).
- Key predictors identified include diabetes, NYHA grade, jugular venous pressure, loud P2, systolic dysfunction, anemia, albuminuria, dwelling location, and cardiothoracic ratio.
- Significant predictors like diabetes (OR=6.230) and raised JVP (OR=7.099) were noted.
Conclusions:
- The prevalence of Type 2 CRS among chronic heart failure patients in Jos, Nigeria, is high.
- Early screening for CKD in heart failure patients and timely nephrologist referral are essential.
- Interventions targeting identified predictors can help prevent progression to end-stage renal disease (ESRD).
Background:
Type 2 cardiorenal syndrome (Type 2 CRS) describes a relationship in which chronic congestive heart failure causes a progressive and permanent chronic kidney disease. Heart failure (HF) and chronic kidney disease (CKD) share similar cardiovascular risk factors and have a bi-directional relationship. A comprehensive approach including early screening of HF patients for CKD as well as management involving the nephrologist and cardiologist will most definitely reduce morbidity and mortality. The aim of this study was to determine the prevalence of and correlates for Type 2 CRS among HF patients in JUTH, Jos-Nigeria.
Methodology:
A hospital-based cross-sectional descriptive study carried out in JUTH involving 120 patients with chronic HF recruited consecutively. History, physical examination and laboratory investigations including urinalysis using albustix were performed on all subjects. CKD was determined using estimated glomerular function rate (eGFR) and persistent albuminuria. The data were analyzed using Epi Info (CDC, Atlanta GA) and p-values <0.05 were considered statistically significant.
Results:
The mean age of the participants was 52.00 ± 11.44 years, majority of whom were females consisting of 58.3%. The prevalence of CRS was 37.5%. Majoity (66.7%) of the patients had mild CRS, while 26.7% had moderate CRS, and only 6.7% had the severe CRS. The predictors of CRS were diabetes (OR=6.230; CI=2.094-19.093), New York heart Association (NYHA) grading I (OR=0.017; CI=0.002-0.142) and II (OR=0.089; CI=0.016-0.483), raised jugular venous pressure (JVP) (OR=7.099; CI=2.671-18.865), loud pulmonary component of the second heart sound (P2) (OR=3.769; CI=1.726-8.232), systolic dysfunction (EF<45%) (OR=3.316; CI=1.487-7.395), anaemia (OR=5.091; CI=1.657-15.640), albuminuria (OR:0.014, CI=0.004-0.052), rural/suburban dwelling (OR=2.875; CI=1.335-6.192) and increased cardiothoracic ratio (CTR) (OR=3.237; CI=1.019-10.278).
Conclusion:
The frequency of Type 2 CRS among CHF patients in JUTH was high. The predictors of chronic CRS include diabetes mellitus, NYHA grade, raised JVP, loud P2, systolic dysfunction, anaemia, albuminuria, rural/suburban dwelling and increased CTR. These findings highlight the urgent need to incorporate screening for CKD among stable heart failure patients at regular intervals, and early referral to the nephrologist to prevent further deterioration to ESRD.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VII: Nursing Interventions
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure I: Introduction
Pathophysiology of Heart Failure